Newly diagnosed with thyroid cancer. What do I need to know

May 8, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Thyroid Cancer Diagnosis

I'm sorry you're facing this diagnosis. Here's what you should know as you begin your cancer journey:

What Thyroid Cancer Is

Your thyroid is a small, butterfly-shaped gland in your neck that produces hormones controlling metabolism and growth. Thyroid cancer occurs when malignant cells develop in this gland. The good news: thyroid cancer is often highly treatable, and many patients have excellent outcomes.

Key Information You'll Need

Type of thyroid cancer matters greatly. There are several types:

  • Papillary thyroid cancer (most common, ~80% of cases) - typically grows slowly
  • Follicular thyroid cancer (~15%) - usually slower-growing
  • Medullary thyroid cancer (~3%) - requires different management
  • Anaplastic thyroid cancer (~1%) - more aggressive, requires urgent treatment
  • Thyroid lymphoma (rare) - different treatment approach

Your pathology report will specify which type you have—this is crucial information.

What Tests You'll Need

Your care team will likely order:

  • Thyroid function tests (TSH, free T4) - measure hormone levels
  • Imaging (ultrasound, CT, or radioactive iodine scan) - determine cancer extent
  • Possibly genetic testing - some thyroid cancers have hereditary components

General Treatment Approaches

According to NCCN (National Comprehensive Cancer Network) Guidelines for Thyroid Cancer, treatment typically involves:

  1. Surgery - removing the thyroid (thyroidectomy) is the primary treatment for most types
  2. Radioactive iodine therapy - used after surgery for certain types to destroy remaining thyroid tissue
  3. Thyroid hormone replacement - you'll take medication to replace lost thyroid function
  4. Monitoring - regular follow-up with blood tests and imaging

For advanced cases, targeted therapies or other systemic treatments may be considered.

Critical Questions to Ask Your Oncologist

  1. What type and stage of thyroid cancer do I have? (Get the specific pathology details)
  2. Do I need surgery? If so, what extent (partial or total thyroidectomy)?
  3. Will I need radioactive iodine treatment after surgery?
  4. What will my long-term follow-up look like?
  5. Are there any genetic factors I should know about, or should my family be screened?
  6. What are the side effects of treatment, and how will they be managed?

What to Do Next

  • Request your pathology report - read it carefully and bring it to your first oncology appointment
  • Ask for a referral to an endocrinologist - they specialize in thyroid conditions
  • Consider a second opinion - especially important for treatment planning
  • **Gather your [ID removed] - previous imaging, biopsies, etc.
  • Write down your questions - bring them to appointments

Resources

The American Cancer Society and American Thyroid Association have excellent patient education materials specific to thyroid cancer. The NCI (National Cancer Institute) also provides detailed information at cancer.gov.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2